Dermapharm Holding SE (DMP) — Cash Flow Reinvestment Rate
Dermapharm Holding SE (DMP) has a Cash Flow Reinvestment Rate of 0.30x as of March 2026, reinvesting €11.85 Million (capex €11.85 Million ) from operating cash flow of €39.49 Million. See DMP FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dermapharm Holding SE Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Dermapharm Holding SE across 12 annual periods. For the full cash flow conversion analysis, see Dermapharm Holding SE cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Dermapharm Holding SE (2014–2025)
Year-by-year capital reinvestment analysis for Dermapharm Holding SE. See Dermapharm Holding SE (DMP) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | €51.93 Million | €181.51 Million | €42.12 Million | ▼ -15.1% |
| 2024 | 0.34x | €67.85 Million | €201.38 Million | €38.24 Million | ▼ -83.8% |
| 2023 | 2.08x | €456.97 Million | €219.42 Million | €41.54 Million | ▲ +335.4% |
| 2022 | 0.48x | €138.02 Million | €288.53 Million | €39.01 Million | ▲ +9.4% |
| 2021 | 0.44x | €109.46 Million | €250.37 Million | €61.20 Million | ▲ +30.5% |
| 2020 | 0.34x | €43.93 Million | €131.10 Million | €40.80 Million | ▼ -68.3% |
| 2019 | 1.06x | €106.29 Million | €100.61 Million | €46.44 Million | ▲ +542.0% |
| 2018 | 0.16x | €26.18 Million | €159.13 Million | €25.97 Million | ▼ -80.9% |
| 2017 | 0.86x | €74.75 Million | €86.74 Million | €74.72 Million | ▲ +271.7% |
| 2016 | 0.23x | €17.80 Million | €76.78 Million | €17.76 Million | ▼ -54.8% |
| 2015 | 0.51x | €20.70 Million | €40.38 Million | €14.93 Million | ▼ -18.6% |
| 2014 | 0.63x | €34.19 Million | €54.26 Million | €28.42 Million | — |